SMAS Somatic Systems Inc (CE)

Somatic Systems, Inc. (PINKSHEETS: SMAS) is proud to announce that it has been approved and is now listed in the National Provider registry, and the company has received its National Provider Identifier (NPI) code by the United States Centers for Medicare and Medicaid Services.

This is a significant step in the process of Somatic Systems becoming fully approved by US military health insurance, a system that provides treatment for more than 70 million soldiers, veterans, and dependents. The NPI assignment and acceptance in the NPI Registry is required to be covered by government and military health insurance. Somatic Systems' application was submitted, reviewed, and approved.

Somatic Systems stated it is currently moving forward with the next phases of the approval process, and furthering its military contracts efforts via discussions and strategic partnerships with key military and related personnel. This week, company representatives are meeting with the Veterans Administration and the Disabled American Veterans organization, to discuss their provision of treatment services.

The Military Chronic Pain Crisis

Somatic Systems has been working to provide its proprietary Clinical Somatics pain-care services for US military hospitals and the Veterans Administration. In addition to seeking in-house arrangements at bases and facilities, the company also announced that it is preparing to rollout multiple clinics at military base locations throughout the US, to provide easy access to Clinical Somatics services at a time when the US military is strongly seeking satisfactory pain treatment solutions such as Clinical Somatics -- and following a wave of legislation including the Military Pain Care Act of 2008, which requires the Department of Defense, Veterans Affairs, and Health and Human Services and the Surgeon General of the United States to implement and maintain a pain care initiative in all military health care facilities and for all active and retired military personnel, dependents, and survivors.

Nearly 26 million living Americans have served in the military, and pain is the most common symptom and cause of disability amongst veterans, with more than 40% of returning service members reporting musculoskeletal pain-related problems and symptoms. Additionally, long-term sufferers as well as family members and other dependents of all ages also face pain and other musculoskeletal problems; and this population totals over 70 million people, served by the Veterans Administration. In the face of this, military officials, medical authorities, and government officials have reported frustration that the military does not yet have a satisfactory pain care program in place.

About Somatic Systems, Inc.

Somatic Systems is the worldwide center for Clinical Somatics?, the groundbreaking drug-free, non-surgical approach to pain relief. This proprietary system uses natural, non-invasive movement techniques -- conducted through one-hour hands-on sessions, therapeutic exercises classes, and home exercises lasting as little as 5 minutes a day -- to relieve pain and limitation resulting from accident, trauma and repetitive stress, including back pain, knee pain, joint problems, carpal tunnel syndrome, TMJ, scoliosis, bursitis, sciatica, headaches, tendonitis and more. Clinical Somatics(TM) also provides performance gains and injury prevention for casual and professional athletes.

Somatic Systems is pursuing a 3-part growth strategy, consisting of a nationwide rollout of pain management Somatics Clinics; increased production and distribution of therapeutic videos, books, and other retail self-help Somatics Products; and expanded Somatics Training Programs to supply Clinic practitioners serving medical and orthopedic professionals and institutional and corporate programs. The company operates a suite of web sites offering Somatics information, products, resources, and opportunities, at www.somatics.org.

Safe Harbor Act: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

Contact: For more information visit http://www.somatics.org or contact: Investor Relations 1 877 586-2555